Cargando…

WT1基因和流式细胞术监测骨髓增生异常综合征造血干细胞移植后微小残留病的意义

OBJECTIVE: To investigate the clinical significance of minimal residual disease (MRD) monitoring by using WT1 gene and flow cytometry (FCM) in patients with myelodysplastic syndrome (MDS) who receiving allogeneic stem cell transplantation (allo-HSCT). METHODS: WT1 gene and MDS-related abnormal immun...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348232/
https://www.ncbi.nlm.nih.gov/pubmed/30612401
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.12.006